SEC Tracker
Get the app

Fibrogen KYNB

Mark Eisner (Officer) plans to sell 2,042 KYNB shares, about $34,792

Form
144
Filed
Importance
Routine
Document
Form 144
  1. Approximate sale date: Jun 7, 2023
  2. Broker: ETRADE FINANCIALCORPORATION
  3. Shares acquired by: RESTRICTED STOCK

All of Mark Eisner's insider filings, holdings and planned sales

Form 4s that likely executed this notice (SEC Tracker's match by person, company, dates and shares):

  • Sold 2,042 shares at $17.04 on Jun 7, 2023 ยท Form 4

Written from the Form 144 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Fibrogen files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Armata Pharmaceuticals ARMP public float $21M, Jun 30, 2025
  2. Imunon IMNN public float $21M, Jun 30, 2025
  3. Lunai Bioworks LNAI public float $21M, Dec 31, 2025
  4. Dare Bioscience DARE public float $21M, Jun 30, 2025
  5. Aptose Biosciences APTOF public float $22M, Jun 28, 2025

Data on this page was fetched . The filing on SEC.gov is the record.